ClinVar Miner

Submissions for variant NC_012920.1(MT-ND1):m.3902_3908inv

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen RCV002260595 SCV002540734 likely pathogenic Mitochondrial disease 2022-06-30 reviewed by expert panel curation The m.3902_3908inv (p.DLA199GKV) variant in MT-ND1 has been reported in four unrelated individuals in the literature with primary mitochondrial disease with a range of clinical features including myopathy, exercise intolerance, Leigh syndrome, cardiomyopathy, failure to thrive, lactic acidosis, nephropathy, sensorineural hearing loss, and diabetes mellitus (PS4_moderate; PMIDs: 10775530, 16492986, 27290639, 34135385). Additionally, this expert panel knew of one local family with an affected individual with this variant that the expert panel agreed to include. There are at least three de novo occurrences reported in the literature and this variant in the case reported by the expert panel member also occurred de novo (PM6_strong; PMIDs: 16492986, 10775530, 27290639). There are no large families reported in the medical literature to consider for evidence of segregation. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). E. coli models demonstrated two different functional defects, reduced complex activity and reduced proton translocation (PS3_moderate; PMIDs; 34135385, 35234296). There are no in silico predictors for this type of variant in mitochondrial DNA. In summary, this variant meets criteria to be classified as likely pathogenic for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 Mitochondrial Disease Variant Curation Expert Panel on May 9, 2022. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS4_moderate, PM6_strong, PM2_supporting, PS3_moderate.
OMIM RCV000010383 SCV000030609 pathogenic MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3 2006-03-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.